Vistagen Announces Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder

First positive U.S. Phase 3 study of an investigational therapy for social anxiety disorder in over 15 years


Statistically significant rapid-onset reduction in patient-reported Subjective Units of...

Related Keywords

Columbia University ,New York ,United States ,New York State Psychiatric Institute ,Americans ,Shawn Singh ,Michaelr Liebowitz ,Research Network ,York State Psychiatric Institute ,Exchange Commission ,National Health ,Chief Executive Officer ,Liebowitz Social Anxiety Scale ,Anxiety Disorders Clinic ,Managing Director ,Medical Research Network ,Global Impression ,Annual Report ,Wellness Survey ,Markets ,